Mesenchymal stem cell therapy (INmune Bio)

N/A

Report date: 2025/04/01 17:02:09

Base Information

Drug NameMesenchymal stem cell therapy (INmune Bio)
Drug Alias NameCORDStromAseptic, allogeneic, pooled human umbilical cord derived mesenchymal stromal cells
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsEpidermolysis Bullosa Dystrophica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInmune Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesCell and Gene Therapy CatapultInmune Bio IncGreat Ormond Street Hospital For Children Nhs Foundation Trust
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa Dystrophica
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A